期刊文献+

盐酸吡格列酮的考马斯亮蓝G250光度测定法

Spectrophotometric method for determination of pioglitazone hydrochloride with Coomassie brilliant blue G250
下载PDF
导出
摘要 在pH6.85的0.2mol/LNaH2PO4-Na2HPO4缓冲介质中,盐酸吡格列酮与考马斯亮蓝G250作用,形成离子缔合物,溶液颜色发生明显改变,最大退色波长为570nm,且盐酸吡格列酮的浓度与溶液的退色程度呈良好线性关系,可用光度法测定盐酸吡格列酮。在570nm波长处,盐酸吡格列酮的浓度在1.25×10-6~2.60×10-5mol/L范围内遵守比尔定律,表观摩尔吸光系数ε570为1.26×104L.mol-1.cm-1,检出限为8.20×10-7mol/L。方法具有较高的灵敏度和良好的选择性,用于临床用药中盐酸吡格列酮的测定,结果满意。 In a buffer solution of NaH2POa-Na2HPO4 with a pH value of 6.85, pioglitazone hydrochloride reacted with Coomassie brilliant blue G250 to form an ion-association complex. The colour of solution changed obviously, and the maximum fading wavelength was identified at 570 nm, with the fading eolour intensity being proportional to the concentration of pioglitazone hydroehloride. Thereby a sensitive spectrophotometrie method was developed for determination of pioglitazone hydrochloride. The concentration of pioglitazone hydrochloride in the range of 1.25 × 10^-6 - 2.60 × 10^-5mol/L obeyed the Beer's law at a maximum fading wavelength of 570 nm ; the apparent molar absorptivity ε570 was 1.26 × 10^4 L/(mol·cm) ;and the detection limit was 8.20 × 10^-7 mol/L. This method has high sensitivity and fairly good selectivity,and can be applied to the determination of pioglitazone hydrochloride in medicine samples,with satisfactory results.
出处 《化学试剂》 CAS CSCD 北大核心 2009年第9期705-708,共4页 Chemical Reagents
基金 重庆市教委科研项目(KJ081301) 重庆市涪陵区科委科技计划项目(2008-43) 重庆市高等学校优秀中青年骨干教师资助计划项目[渝教人(2005)2号] 长江师范学院学术带头人资助项目
关键词 分光光度法 盐酸吡格列酮 考马斯亮蓝G250 spectrophotometry pioglitazone hydrochloride Coomassie brilliant blue G250
  • 相关文献

参考文献12

二级参考文献34

  • 1杨梅,邹原,于世钧,李晓辉.阿昔洛韦-过氧化氢-钴(Ⅱ)化学发光体系的研究和应用[J].分析化学,2004,32(9):1237-1239. 被引量:17
  • 2朱鹏祥,钱南萍,魏润新,李伟.盐酸吡格列酮片的HPLC含量测定方法[J].江苏药学与临床研究,2004,12(6):15-16. 被引量:5
  • 3廉江平,张鹏,李小川,李巧如,陈世虎,高建武.高效液相色谱法测定人血浆中盐酸吡格列酮浓度[J].中国药房,2005,16(9):687-688. 被引量:5
  • 4中国药典[S]. 2000版.二部. 189
  • 5叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2001.824.
  • 6Gillies PS, Dunn CJ. Pioglitamne [ J ]. Drugs, 2000, 60 (2) :333.
  • 7Maeshiba Y, Kiyota Y, Yamashita K, et al. Disposition of the new antidiabetic agent pioglitazone in rots, dogs, and monkeys[J]. Arzneim Forsch/Drug Res, 1997, 47(1): 29.
  • 8Zhong WZ, Lakings DB. Determination of pioglitazone in dog serum using solid-phase extraction and high-performance liquid chromatography with ultraviolet (229nm) detection [ J ]. J Chromatcgr B, 1989, 490(2) :377.
  • 9Kiyota Y, Kondo T, Maeshiba Y, et al. Studies on the metabolism of the new antidi abetic agent pioglitazone. Identification of metabolites in rats and dogs [ J ]. Arzneim Forseh/Drug Res, 1997, 47(I): 22.
  • 10Yamashita K, Murakami H, Okuda T, et al. High-performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urine [ J ]. J Chromatogr B,1996, 677(1): 141.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部